ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Inflammation Pharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1625798
This article is part of the Research TopicVolume II: Anti-inflammatory drug development focusing on immune mediated diseasesView all 5 articles
Unique compound with anti-allergic action: inhibition of kinase activity of Lyn by KIRA6
Provisionally accepted- 1Department of Pharmacotherapy, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan
- 2Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, 1-1-1 Daigaku-dori, Sanyo Onoda City, Yamaguchi, Japan
- 3Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan
- 4Faculty of Pharmacy, Yasuda Women's University, 6-13-1 Yasuhigashi, Asakita-ku, Hiroshima, Japan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Mast cells and basophils play important roles in allergic disorders associated with specific antigens and IgE. Crosslinking of high-affinity IgE receptor (FcεRI) by specific antigens activates several tyrosine kinases, such as Lyn and spleen-associated tyrosine kinase (Syk), resulting in the release of calcium ions (Ca 2+ ) from the endoplasmic reticulum (ER) into the cytoplasm. As Ca 2+ release from ER is essential for the release of pro-inflammatory mediators, ER stress-related molecules, inositolrequiring enzyme 1α (IRE1α), may play roles in mast cell and basophil activation. However, the associations between ER stress-related molecules and mast cell and basophil activation remain unclear.In this study, we aimed to investigate the roles of ER stress-related molecules in mast cell and basophil activation. Activation of the IRE1α-spliced form of X-box-binding protein 1 (sXBP1) axis, an ER stress-related pathway, was observed during the antigen-induced activation of mast cells. Moreover, IRE1α inhibitor, KIRA6, suppressed antigen-induced release of pro-inflammatory mediators from RBL-2H3 cells, BMMCs, human basophils, and human mast cells with low doses (< 1 μM). However, to our surprise, IRE1α knockout did not inhibit antigen-induced release of pro-inflammatory mediators.Instead, KIRA6 blocked the antigen-induced activation of Syk by inhibiting kinase activity of Lyn.Additionally, KIRA6 exerted anti-allergic effects in vivo. Overall, our findings suggest that KIRA6 prevents allergic reactions by inhibiting kinase activity of Lyn via an IRE1α-independent pathway.
Keywords: Allergic disorder, Endoplasmic Reticulum Stress, lyn, degranulation, mast cell, basophil
Received: 09 May 2025; Accepted: 30 Jun 2025.
Copyright: © 2025 Matsushima, Matsui, Okamoto, Umeda, Kakimoto, Mino, Nakagawa, Ishii, Matsuo, Matsubara, Tanaka, Yoshii, Goda, Yanase, Hosoi and Ozawa. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Yuhki Yanase, Department of Pharmacotherapy, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan
Toru Hosoi, Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Sanyo-Onoda City University, 1-1-1 Daigaku-dori, Sanyo Onoda City, Yamaguchi, Japan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.